| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2014-12-05 15:49:26 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm will Hold Third Quarter 2014 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its third quarter 2014 investor conference webinar scheduled on December 9, 2014 at 16:00 (EET). Webinar will be hosted by the member of the management board Salvis Lapiņš. The presentation will be in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyse the financial results of the third quarter 2014. After the presentation investors will be welcomed to ask questions. Due to the limited webinar time, please send in your questions in advance till December 8 to e-mail: ieva.kadakovska@nasdaq.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia Information
prepared by: |
| Pielikumi |
|